News | February 27, 2009

Mercy Hospital First in Miami-Dade to Implant Insertable Cardiac Monitor

February 27, 2009 - Dr. Alberto Interian Jr., medical director of the Mercy Hospital Arrhythmia Syncope Center, is the first doctor in Miami-Dade County, FL to implant an innovative cardiac monitoring device for patients with irregular heart rhythms (arrhythmias), or recurrent, unexplained fainting (syncope).
The Medtronic Reveal XT Insertable Cardiac Monitor (ICM) device monitors patients 24 hours a day, every day for up to three years, recording important cardiac rhythm trend data that may allow a physician to confirm or rule out an abnormal heart rhythm more definitively than other tests.

“Cardiac arrhythmias are unpredictable,” said Dr. Interian. “The Reveal XT device gives me a long-term monitoring option that further assists me in making a diagnosis and determining the appropriate treatment for my patients.”

Physicians may choose the Reveal XT monitor for their patients with suspected arrhythmias in difficult-to-diagnose patients for whom long-term cardiac rhythm trending data may aid in a more informed diagnosis; or in syncope patients with known or suspected atrial fibrillation (AF), where the heart quivers and cannot effectively pump blood to the body’s organs.

The ICMs are also an option for physicians seeking to detect the presence of atrial arrhythmias (irregular heart rhythms in the upper chambers, also known as AT), including asymptomatic episodes, or to monitor the amount of time a patient is in AT/AF to assess whether medical treatment is necessary or should be adjusted.

Placed just under the skin of the chest area using local anesthesia during a simple outpatient procedure, the device weighs just 15 grams and is approximately the size of a jump drive. Unlike a pacemaker or implantable cardioverter-defibrillator, there are no leads or tiny wires that extend from the device into the heart’s chambers. To store an electrocardiogram (ECG), a patient places a hand-held, pager-sized assistant over the device and presses a button. The physician can then analyze the stored information, transmitted via the Medtronic CareLink Network or during an in-office patient visit, and determines whether the episode was caused by an abnormal heart rhythm.

For more information: www.mercymiami.org

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
Overlay Init